Valproic acid (VPA) is an antiepileptic drug used in the treatment of a wide variety of human seizures including generalized absence (GA) (petit mal) seizures. The mechanism of action of VPA in controlling GA seizures is not known. We tested the effects of VPA on the Ca 2÷ current components of acutely dissociated rat nodose ganglion neurons. VPA reduced the low-threshold (T) Ca 2. current at clinically relevant concentrations but had no effect on the high-threshold (N and L) current components. The effect on T current was concentration-dependent and most apparent at peak current. There was little effect seen on late current. VPA did not affect the rate or voltage-dependency of T current activation. The selective reduction of T current may be a means by which VPA is effective in controlling GA seizures.
Valproic acid (VPA) is an antiepileptic drug used in the treatment of a wide spectrum of human seizure types including generalized tonic-clonic, generalized absence (GA), myoclonic, secondary generalized tonic-clonic and simple and complex partial seizures with or without secondary generalization. Despite VPA's broad clinical use and therapeutic efficacy, its mechanism of action in controlling seizures is not understood completely. Hypotheses include augmenting y-aminobutyric acid (GABA)-mediated inhibition by enhancing presynaptic release of GABA [3, 18, 22] and useand voltage-dependent limitation of high-frequency repetitive firing of Na+-dependent action potentials [20] . Neither of these hypotheses adequately explains all of VPA's antiepileptic activity and, specifically, its activity against GA seizures.
Ethosuximide and dimethadione, drugs effective in the control of GA seizures, have recently been shown to reduce Ca 2+ currents in thalamic and sensory neurons [4, 8] . The Ca 2+ current components recorded in these tissues include a transient lowthreshold current (T), a transient high-threshold current (N), and a slowly inactivat-ing high-threshold current (L). Studies in thalamic neurons [4, 15] and inferior olivary neurons [16, 17] suggest that T currents are responsible for the low-threshold Ca 2 + spike that underlies oscillatory bursting in these cells. The low-threshold Ca 2+ spike may also be involved in the generation of thalamocortical rhythms, such as sleep spindles, and possibly, the abnormal electroencephalographic 3Hz spike-andwave rhythm seen in human GA seizures. Since ethosuximide, dimethadione and VPA are all capable of blocking pentylenetetrazol-induced seizures in animals [14] and are effective in treating GA seizures, these drugs may have a common mechanism of action. Ethosuximide and dimethadione selectively reduced the T current in thalamic neurons [4] , although VPA did not have this effect. However, studies in area CA 1 of rat hippocampus suggest that VPA may act by increasing K * currents and/or reducing Ca 2+ currents [2, 7, 21] .
We chose therefore to examine the effect of VPA on the Ca 2+ current components of acutely dissociated rat nodose ganglion neurons. Nodose neurons were easy to prepare and were similar to dorsal root ganglion neurons with regard to Ca 2 + current components [6, 9] and antiepileptic drug effects [8] . Most importantly, nodose neurons had Ca 2+ current components [10, l l] similar to neurons in rat thalamus [5, 23] , hypothalamus [1] and dorsal horn [12] . These latter considerations suggested that antiepileptic drug effects on nodose neurons could be similar to effects on central neurons involved in seizure activity. Our results show that VPA produced a reversible reduction of T current in nodose neurons.
We determined the effects of VPA using the whole cell variation of the patch clamp technique. Acutely dissociated neurons were obtained from nodose ganglia of 6-10 day old rats according to the method described by Ikeda et al. [13] , as modified by Gross et al. [11] . Briefly, the ganglia were removed, placed in oxygenated Ca 2+-and Mg2+-free buffer and collagenase (1 mg/ml) was added. Following addition of enzyme inhibitor (5% fetal calf serum), the cells were triturated, centrifuged, resuspended, plated and incubated at 37°C in a 93% air/7% CO2 atmosphere. Recordings were made using glass micropipettes (1.5-3.0 M,Q) filled with a solution of (in mM): CsC1 140, CsOH 30, HEPES 10, EGTA 10, ATP 5 and GTP 0.1 (pH 7.2-7.3, ~300 mOsm). Cells were bathed in a solution of (in mM): choline CI 67, TEA 100, glucose 5.6, KC1 5.3, CaCI2 5.0, MgCI2 0.8, HEPES 10 (pH 7.35, ~320 mOsm). Cesium and TEA were used to block K + currents; choline was used to block Na + currents. Following sealing of the electrode to the cell and rupture of the membrane patch, the cell was hyperpolarized to a holding potential (Vh) = --90 mV to fully remove steadystate inactivation of T currents. The program pCLAMP (Axon Instruments) was used to generate voltage step commands and to digitize (5.6 kHz) and store current traces. All experiments were conducted at room temperature.
T currents were evoked at clamp potentials (V~) at or positive to -55 mV. Typically, T currents were evoked by using voltage steps of 100 ms duration delivered every 5 s in 5 mV increments ranging from a V~ of -65 to -20 mV. Three measuremerits of T current magnitude were made: the peak inward current, the current at 100 ms and the area under the current curves (total current). Maximal T current was defined as the largest evoked peak T current evoked at a V~ (usually -35 mV) nega-tive to that at which more slowly inactivating current components (N and L) were evoked. This resulted in slight underestimation of T current magnitude but allowed for examination of those currents with little high-threshold current contamination. T currents were stable and showed little change in amplitude over the course of an experiment. T current magnitudes varied among neurons from barely detectable to greater than 1 nA. Many neurons had maximal T currents less than 200 pA that were difficult to analyze quantitatively and thus were assessed only for a possible VPA effect. For VPA-responsive neurons, the potential effect of VPA on T current activation and inactivation rates was assessed by normalizing VPA-reduced currents to control peak T currents and superimposing the current traces for comparison. Currents containing N and L components were evoked from a lib at or negative to --80 mV at a l/c at or positive to --20 mV. These currents were evoked every 60 s and, in contrast to T currents, declined 30-50% during a 20 min recording. All currents were leak subtracted for analysis. VPA (100-1000/IM) was prepared daily by dissolving its sodium salt in external solution used as diluent. VPA was tested initially at 1 mM to screen for drug effect and then tested within the range of antiepileptic levels of free VPA for adult humans (17.5-210/tM) [19] . The drug was applied by pressure ejection (1 psi) from a blunttipped micropipette positioned 50/~m from the cell soma before and during voltage step commands. Currents were evoked during delivery of the drug in order to attain a constant drug concentration at the soma. Micropipettes containing different concentrations of drug were substituted sequentially with control and recovery trials and were removed from the bath solution when not in use. Application of diluent alone had no effect on evoked currents.
VPA reduced T currents in 35/39 neurons of which 14 were suitable for quantitative analysis. 500/IM in a single neuron. VPA reduced peak T current by 9% (100/tM), 14% (250 /zM) and 34% (500/iM), an effect that was fully reversible within several seconds. Total T current reduction was similar: 10% (100/IM), 19% (250/tM) and 27% (500 FtM) (data not shown). VPA reduced T current in a concentration-dependent manner in all cells tested, but in most cases, the effect was more modest. For example, in 14 VPA-responsive cells, tested with either single or multiple concentrations of VPA, T current reduction was 7% at 100/tM, 13% at 200/~M and 16% at 1000/tM (Fig. 
IB).
To determine if the effect of VPA was voltage-dependent, we tested the effect of VPA at several Vc ( Fig. 2A) . Currents were evoked at a Vc ranging from -65 to -20 mV from a Vh = --90 mV. VPA reduced T current amplitude at a Vc at or positive to -55 mV. Fig. 2B shows the current-voltage relation of this cell over the activation range for T current. There was no effect of VPA on voltage-dependency and the percent reduction of T current by VPA was relatively constant throughout the activation range (29-36%). T currents appeared to have activation kinetics governed by a single time constant whereas current inactivation appeared to have an early phase (,~ 30 ms following peak) and a late phase (beyond ,~ 30 ms following peak), suggesting more than one time constant for inactivation. VPA-reduced currents normalized to control peak T currents showed no significant difference in activation rate or the early phase of inactivation. However, the late phase of inactivation showed little VPA effect. This raises the possibility that T current may have a VPA non-responsive inactivating phase or that the late phase of inactivation may be due to high-threshold current components on which VPA showed little or no effect (data not shown).
The main finding of this study is that VPA reduced whole cell voltage-dependent T currents in nodose neurons when tested at concentrations within the therapeutic range of antiepileptic free plasma levels in man. The reduction of T current was small in most of the cells tested and less than that shown for ethosuximide and dimethadione in thalamic relay neurons [4] . However, it is possible that small reductions of this current in central neurons could prevent the occurrence of the low-threshold Ca 2+ spike, and thereby, be significant in the control of phasic electrical discharges seen in some types of seizures. VPA showed no effect on the voltage-dependency of T current activation, or on the rates of activation or inactivation. These results were similar to those found in thalamic neurons for ethosuximide and dimethadione [4] . These findings suggest that the mechanism of action of these drugs on T currents may be similar and that T current reduction may be one of multiple mechanisms of action of VPA in central neurons. For example, VPA, phenytoin, and carbamazepine are all effective in controlling certain partial and generalized seizures, presumably by use-and voltage-dependent limitation of high frequency repetitive firing of action potentials [20] . However, phenytoin and carbamazepine are ineffective against GA seizures and do not reduce T currents in thalamic neurons at clinically relevant concentrations [4] . This suggests that if T currents are involved in the expression of GA seizures, reduction of these currents may underlie the effectiveness of VPA against this seizure type.
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